Literature DB >> 8773954

Precipitation of proteins in supercritical carbon dioxide.

M A Winters1, B L Knutson, P G Debenedetti, H G Sparks, T M Przybycien, C L Stevenson, S J Prestrelski.   

Abstract

Supercritical CO2 was used as an antisolvent to form protein particles that exhibited minimal loss of activity upon reconstitution. Organic protein solutions were sprayed under a variety of operating conditions into the supercritical fluid, causing precipitation of dry, microparticulate (1-5 microns) protein powders. Three proteins were studied: trypsin, lysozyme, and insulin. Amide I band Raman spectra were used to estimate the alpha-helix and beta-sheet structural contents of native and precipitate powders of each protein. Analysis of the Raman spectral revealed minimal (lysozyme), intermediate (trypsin), and appreciable (insulin) changes in secondary structure with respect to the commercial starting materials. The perturbations in secondary structure suggest that the most significant event during supercritical fluid-induced precipitation involved the formation of beta-sheet structures with concomitant decreases of alpha-helix. Amide I band Raman and Fourier-transform infrared (FTIR) spectra indicate that higher operating temperatures and pressures lead to more extensive beta-sheet-mediated intermolecular interactions in the precipitates. Raman and FTIR spectra of redissolved precipitates are similar to those of aqueous commercial proteins, indicating that conformational changes were reversible upon reconstitution. These results suggest that protein precipitation in supercritical fluids can be used to form particles suitable for controlled release, direct aerosol delivery to the lungs, and long-term storage at ambient conditions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8773954     DOI: 10.1021/js950482q

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  24 in total

1.  Bacterial inactivation by using near- and supercritical carbon dioxide.

Authors:  A K Dillow; F Dehghani; J S Hrkach; N R Foster; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Protein inhalation powders: spray drying vs spray freeze drying.

Authors:  Y F Maa; P A Nguyen; T Sweeney; S J Shire; C C Hsu
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

3.  Generation of fine powders of recombinant human deoxyribonuclease using the aerosol solvent extraction system.

Authors:  Rana T Bustami; Hak-Kim Chan; Theresa Sweeney; Fariba Dehghani; Neil R Foster
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

4.  Effect of vacuum drying on protein-mannitol interactions: the physical state of mannitol and protein structure in the dried state.

Authors:  Vikas K Sharma; Devendra S Kalonia
Journal:  AAPS PharmSciTech       Date:  2004-02-17       Impact factor: 3.246

5.  Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application.

Authors:  Yuh-Fun Maa; Mahmoud Ameri; Robert Rigney; Lendon G Payne; Dexiang Chen
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

Review 6.  Stabilization of proteins in dry powder formulations using supercritical fluid technology.

Authors:  Natasa Jovanović; Andréanne Bouchard; Gerard W Hofland; Geert-Jan Witkamp; Daan J A Crommelin; Wim Jiskoot
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

Review 7.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

Review 8.  Particle engineering for pulmonary drug delivery.

Authors:  Albert H L Chow; Henry H Y Tong; Pratibhash Chattopadhyay; Boris Y Shekunov
Journal:  Pharm Res       Date:  2007-03       Impact factor: 4.200

9.  Formulation of High-Performance Dry Powder Aerosols for Pulmonary Protein Delivery.

Authors:  Erin M Wilson; J Christopher Luft; Joseph M DeSimone
Journal:  Pharm Res       Date:  2018-08-23       Impact factor: 4.200

10.  Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process.

Authors:  Kavitha Koushik; Uday B Kompella
Journal:  Pharm Res       Date:  2004-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.